WorldQuant Millennium Advisors
REGN icon

WorldQuant Millennium Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

WorldQuant Millennium Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221M Buy
353,970
+253,301
+252% +$172M 0.76% 19
2026
Q1 		$77.8M Buy
100,669
+41,315
+70% +$31.6M 0.3% 95
2025
Q4 		$45.8M Sell
59,354
-8,030
-12% -$5.45M 0.18% 142
2025
Q3 		$37.9M Buy
+67,384
New +$38.1M 0.16% 153
2025
Q2 		– Sell
-129,801
Closed -$82.3M – 563
2025
Q1 		$82.3M Buy
129,801
+24,492
+23% +$16.8M 0.52% 56
2024
Q4 		$75M Sell
105,309
-15,966
-13% -$13.4M 0.49% 54
2024
Q3 		$127M Buy
+121,275
New +$135M 0.93% 22
2024
Q2 		– Sell
-449
Closed -$432K – 462
2024
Q1 		$432K Sell
449
-1,049
-70% -$997K 0.01% 332
2023
Q4 		$1.32M Sell
1,498
-15,682
-91% -$12.9M 0.02% 285
2023
Q3 		$14.1M Buy
17,180
+606
+4% +$476K 0.22% 142
2023
Q2 		$11.9M Sell
16,574
-5,121
-24% -$3.95M 0.2% 153
2023
Q1 		$17.8M Buy
+21,695
New +$16.4M 0.33% 102
2022
Q1 		– Sell
-45,312
Closed -$28.6M – 349
2021
Q4 		$28.6M Buy
45,312
+38,879
+604% +$23.9M 0.57% 51
2021
Q3 		$3.89M Buy
+6,433
New +$3.99M 0.09% 225
2021
Q2 		– Sell
-12,449
Closed -$5.89M – 396
2021
Q1 		$5.89M Buy
+12,449
New +$6.06M 0.13% 216
2020
Q4 		– Sell
-4,175
Closed -$2.34M – 356
2020
Q3 		$2.34M Sell
4,175
-3,284
-44% -$1.99M 0.06% 276
2020
Q2 		$4.65M Sell
7,459
-2,361
-24% -$1.34M 0.11% 228
2020
Q1 		$4.79M Buy
+9,820
New +$4.05M 0.12% 203
2018
Q3 		– Sell
-39,286
Closed -$13.6M – 293
2018
Q2 		$13.6M Buy
+39,286
New +$12.3M 0.52% 69

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

WorldQuant Millennium Advisors's REGN Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 252% in Q2 2026, buying an estimated $172M and bringing the position to 353,970 shares worth $221M. The position accounts for 0.76% of the portfolio, ranked #19.

WorldQuant Millennium Advisors first reported a position in REGN in Q2 2018 and has held it in 19 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • WorldQuant Millennium Advisors held 353,970 shares of Regeneron Pharmaceuticals worth $221M as of Q2 2026.
  • WorldQuant Millennium Advisors bought 253,301 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $172M.
  • Regeneron Pharmaceuticals made up 0.76% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #19 holding.
  • WorldQuant Millennium Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 19 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.